期刊文献+

AT-1受体、ACE基因静默对肝星状细胞NF-κB活性的影响 被引量:3

Effect of angiotensin II type 1 receptor and angiotensin-converting enzyme gene silencing on nuclear factor-κB activity in hepatic stellate cells
下载PDF
导出
摘要 目的探讨肝星状细胞血管紧张素Ⅱ1型(AT-1)受体及血管紧张素转换酶(ACE)基因静默对肝星状细胞NF-κB活性的影响。方法采用HSC-T6细胞系。构建pSilencer/AT-1α受体siRNA、pSilencer/ACE siRNA质粒,将其转染HSC-T6,予10-6mol/L血管紧张素Ⅱ(AngⅡ)或血管紧张素转换酶抑制剂(ACEI)干预,设立对照组。凝胶电泳移动抑制实验(EMSA)检测NF-κB DNA结合活性。结果EMSA显示:AngⅡ可刺激肝星状细胞NF-κB DNA结合活性增强;pSilencer/AT-1α受体siRNA转染细胞后可显著抑制AngⅡ诱导的NF-κB DNA结合活性增强。pSilencer/ACE siRNA转染细胞后可抑制NF-κB DNA结合活性。结论AT-1受体、ACE基因静默可抑制肝星状细胞NF-κB的活性。 Objective To investigate the effect of angiotensin Ⅱ (AngⅡ) type 1 (AT-1) receptor and angiotensin-converting enzyme (ACE) gene silencing on nuclear factor-κB (NF-κB) activity in hepatic stcllatc cells (HSCs). Methods pSilencer/AT-1 α receptor siRNA and pSilencer/ACE siRNA plasmids were transfected into cultured HSC-T6 cells, which were subsequently stimulated by 10-6 mol/L AngII or ACE inhibitor (ACEI). The DNA binding activity of NF-κB in the transfected cells was analyzed using electrophoretic gel mobility shift assay (EMSA). Results Gel shift studies showed that stimulation of the HSCs by AngII markedly increased the DNA-binding activity of NF-κB, which was inhibited by the transfection with pSilencer/ AT- 1 α receptor siRNA plasmid or pSilencer/ACE siRNA plasmid. Conclusion AT- 1 α receptor and ACE gene silencing result in inhibition of NF-κB activity in HSCs in vitro.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第3期402-404,共3页 Journal of Southern Medical University
基金 国家自然科学基金(30500243) 广东省中医药局科研基金(1050056)
关键词 肝星状细胞 核因子-ΚB 血管紧张素Ⅱ1型受体 血管紧张素转换酶 hepatic stellate cells angiotensin Ⅱ type 1 receptor angiotensin-converting enzyme nuclear factor-κB
  • 相关文献

参考文献11

  • 1Powell EE, Edwards-Smith CJ, Hay JL, et al. Host genetic factors influence disease progression in chronic hepatitis C[J].Hepatology, 2000, 31: 828-33.
  • 2Dong Hua Yang Ming Qing Zhang Jiang Du Chong Xu Oiao Ming Liang Ji Fang Mao Han Rong Qin Zi Rong Fan Department of Gastroenterology,Zhujiang Hospital,the First Military Medical University,Guangzhou 510282,China Laboratory of Molecular Biology,Zhujiang Hospital,the First Military Medical University,Guangzhou,China Departrnent of Biochemistry,the Second Military Medical University,Shanghai,China.Inhibitory effect of IGF-Ⅱ antisense RNA on malignant phenotype of hepatocellular carcinoma[J].World Journal of Gastroenterology,2000,6(2):266-267. 被引量:54
  • 3Tuncer I, Ozbek H, Ugras S, et al. Anti-fibrogenic effects ofcaptopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis [ J ]. Exp Toxicol Pathol, 2003, 55: 159-66.
  • 4李旭,孟莹,张振书,杨希山,吴平生.培哚普利和氯沙坦抗实验性肝纤维化的研究[J].中华医学杂志,2003,83(14):1241-1245. 被引量:10
  • 5Paizis G, Gilbert RE, Cooper ME, et al. Effect ofangiotensin Ⅱ type 1 receptor blockade on experimental hepatic fibrogenesis [J]. J Hepatol, 2001, 35: 376-85.
  • 6Nie L, Imamura M, Itoh H, et al. Pitavastatin enhances the antifibrogenesis effects of candesartan, an angiotensin Ⅱ receptor blocker, on CCl4-induced liver fibrosis in rats[J]. J UOEH, 2004, 26: 165-77.
  • 7Hellerbrand C, Jobin C, Licato LL. Cytokines induce NF-kappa B in activated but not quiescent rat hepatic satellite cells [J]. Am J Physiol, 1998, 275: G269-78.
  • 8Taub R. Blocking NF-kappa B in the liver: the good and bad news[J]. Hepatology, 1998, 27: 1445-6.
  • 9Li X, Meng Y, Wu PS, et al. Angiotensin Ⅱ and aldosterone stimulating NF-κB and AP-1 activation in hepatic fibrosis of rat[J]. Regul Pept, 2007, 138: 15-25.
  • 10Baldwin AS. The NF-KB and IKB proteins: new discoveries and insights[J].Annu Rev Immunol, 1996, 14: 649-81.

二级参考文献16

  • 1Brilla CG,Maisch B,Zhou G,et al.Hormonal regulation of cardiac fibroblast function.Eur Heart J, 1995,16 Suppl C:45-50.
  • 2Harris RC, Martinez-Maldonado M. Angiotensin II-mediated renal injury. Miner Electrolyte Metab, 1995,21:328-335.
  • 3Marshall RP, Mcanulty RJ, Laurent GJ, et al. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med, 2000,161:1999-2004.
  • 4Leung P S, Yao X Q, Chan H C, et al. Differential gene expression of angiotensin II receptor subtypes in the epididymides of mature and immature rats. Life sciences, 1998,62:461-468.
  • 5Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol, 1991,13:372-374.
  • 6Kim S, Zhan Y, Izumi Y, et al. In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension. Arterioscler Thromb Vasc Biol, 2000,20:2539-2545.
  • 7Campbell SE, Katwa LC. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol, 1997,29:1947-1958.
  • 8Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med, 2000, 161:1999-2004.
  • 9Hamaguchi A, Kim S, Izumi Y, et al. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. Hypertension, 1999, 34:126-131.
  • 10Kelly DJ, Cox AJ, Tolcos M, et al. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int, 2002, 61:31-39.

共引文献62

同被引文献36

  • 1李立新,王宇,张忠涛,宋明,薛建国,阴赪宏,尹珊珊,马雪梅.血管紧张素Ⅱ受体拮抗剂抗纤维化及对Ⅰ型胶原基因表达影响的实验研究[J].中华肝胆外科杂志,2004,10(1):55-58. 被引量:8
  • 2窦京涛,母义明,陆菊明,潘长玉.血管紧张素Ⅱ受体拮抗剂对大鼠脂肪分泌瘦素、脂联素和TNF-α的影响[J].解放军医学杂志,2006,31(2):138-140. 被引量:13
  • 3Wen-ying CHOU,Cheng-nan LU,Tsung-hsing LEE,Chia-ling WU,Kung-sheng HUNG,Allan M CONCEJERO,Bruno JAWAN,Cheng-haung WANG.Electroporative interleukin-10 gene transfer ameliorates carbon tetrachlo-ride-induced murine liver fibrosis by MMP and TIMP modulation[J].Acta Pharmacologica Sinica,2006,27(4):469-476. 被引量:25
  • 4World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks [ R ]. Geneva: World Health Organization, 2009.
  • 5Wellen K E, Hotamisligil G S. Inflammation, stress, and diabetes [J]. J Clin Invest, 2005, 115(5) : 1111 -1119.
  • 6Abuissa H, Jones P G, Marso S P, et al. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention for type 2 diabetes : a meta-analysis of randomized clinical trials [ J ]. J Am Coil Cardiol, 2005, 46(5): 821-826.
  • 7Poulos S P, Dodson M V, Hausman G J. Cell line models for differentiation: preadipocytes and adipocytes[ J]. Exp Biol Med (Maywood), 2010, 235(10) : 1185 -1193.
  • 8Koh Y J, Cha D S, Ko J S, et al. Anti-inflammatory effect of Taraxacum ofilcinale leaves on lipopolysaccharide-induced inflammatory responses inRAW 264.7 cells[J]. J Med Food, 2010, 13(4) : 870-878.
  • 9Freshney R I. Basic principles of cell culture [ M ]//Vunjak-Novakovic, Freshney R I. Culture of ceils for tissue engineering. Hoboken: John Wiley & Sons Inc, 2006:3 -22.
  • 10Perret-Guillaume C, Joly L, Jankowski P, et al. Benefits of the RAS blockade: clinical evidence before the ONTARGET study[ J]. J Hypertens, 2009, 27 ( Suppl 2) : S3 -S7.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部